New Key Statistics Module, Z-Score and F-Score
SHSE:605116 Key Ratios
Market Cap ¥ M | 9,781.18 |
Enterprise Value ¥ M | 9,540.75 |
P/E(ttm) | 25.89 |
PE Ratio without NRI | 24.88 |
Forward PE Ratio | 19.11 |
Price/Book | 4.70 |
Price/Sales | 6.91 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 57.19 |
Payout Ratio % | 0.23 |
Revenue (TTM) ¥ M | 1,440.00 |
EPS (TTM) ¥ | 0.93 |
Beneish M-Score | -2.38 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.10 |
y-y EBITDA Growth Rate % | 85.90 |
EV-to-EBIT | 20.47 |
EV-to-EBITDA | 20.47 |
PEG | 1.90 |
Shares Outstanding M | 406.20 |
Net Margin (%) | 26.53 |
Operating Margin % | 26.81 |
Pre-tax Margin (%) | 29.69 |
Quick Ratio | 1.33 |
Current Ratio | 2.22 |
ROA % (ttm) | 15.11 |
ROE % (ttm) | 19.69 |
ROIC % (ttm) | 21.13 |
Dividend Yield % | 0.91 |
Altman Z-Score | 8.67 |
SHSE:605116 Number of Guru Trades
SHSE:605116 Volume of Guru Trades
Gurus Latest Trades with SHSE:605116
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:605116 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aurisco Pharmaceutical Co Ltd Insider Transactions
No Available Data